Effect of Chitosan on Epithelial Cell Tight Junctions

Pharmaceutical Research

Volumn 21, Issue 1, 2004, Pages 43-49

  Smith, Jennifer ^a   Wood, Edward ^a   Dornish, Michael ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b FMC BioPolymer AS   (Norway)

Author keywords

Chitosan glutamate; Occludin; TEER; Tight junctions; ZO 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHITOSAN; HORSERADISH PEROXIDASE; OCCLUDIN; PROTEIN ZO1;

ANALYSIS; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; CYTOSOL; DRUG EFFECT; ELECTRIC RESISTANCE; EPITHELIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; TIGHT JUNCTION; WESTERN BLOTTING;

CACO-2 CELLS; CELL MEMBRANE; CELL SURVIVAL; CHITIN; CHITOSAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; TIGHT JUNCTIONS;

EID: 1642579659     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000012150.60180.e3     Document Type: Article

References (22)

1. O. Skaugrad, A. Hagen, B. Borgersen, and M. Dornish. Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol. Genet. Eng. Rev 16:23-40 (1999).
2. P. Berscht, B. Nies, A. Leibendorfer, and J. Kreuter. In vitro evaluation of biocompatibility of different wound dressing materials. J. Mat. Sci. Mater. Med. 6:201-205 (1995).
3. M. Dornish, A. Hagen, E. Hansson, C. Pecheur, F. Verdier, and O. Skaugrad. Safety of Protasan: Ultrapure chitosan salts for biomedical and pharmaceutical use. In A. Domard, G. Roberts, and K. Varum (eds.), Advances of Chitin Sci. Vol 2. Eds. Jaques Andre, Lyon, 1997, pp. 694-670.
4. H. Onishi and Y. Machida. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175-182 (1999).
5. A. Singla and M. Chawla. Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53:1047-1067 (2001).
6. N. Kanikkannan, K. Kandimalla, S. Lamba, and M. Singh. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 6:593-608 (1999).
7. G. Borchard, H. Lussen, A. deBoer, J. Verhoef, C. Lehr, and H. Junginger. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Release 39:131-138 (1996).
8. V. Dodane, M. Amin Khan, and J. Merwin. Effect of chitosan on Caco-2 on epithelial permeability and structure. Int. J. Pharm. 182:21-32 (1999).
9. A. Kotze, H. Lussen, A. de Boer, J. Verhoef, and H. Junginger. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur. J. Pharm. Sci. 7:145-151 (1998).
10. G. Ranaldi, I. Marigliano, I. Vespignani, G. Perozzi, and Y. Sambuy. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line. J. Nut. Biochem. 13:157-167 (2002).
11. A. Shaw. Modelling epithelial tissues in vitro. In A. Shaw (Ed.), Epithelial Cell Culture: A Practical Approach. 1st ed. Oxford University Press, Oxford, 1996, pp. 1-16.
12. B. Denker and S. Nigam. Molecular structure and assembly of the tight junction. Am. J. Physiol. 274:F1-F9 (1998).
13. M. Cerijido, L. Shoshani, and R. Contreras. Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity. Am. J. Physiol. 279:G477-G482 (2000).
14. C. Klingler, U. Kneisel, S. Bamforth, H. Wolburg, B. Engelhardt, and W. Risau. Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors. Histochem. Cell Biol. 113:349-361 (2000).
15. T. Tsukamoto and S. Nigam. Tight junction proteins form large complexes and associate with the cytoskeleton in an ATP depletion model for reversible junction assembly. J. Biol. Chem. 272: 16133-16139 (1997).
16. E. Hughson and R. Hirt. Assessment of cell polarity. In A. Shaw (ed.), Epithelial Cell Culture: a Practical Approach. Oxford University Press, New York, 1996, pp. 37-66.
17. H. Holme, A. Hagen, and M. Dornish. Influence of chitosans on permeability of human intestinal epithelial (Caco-2) cell: the effect of molecular weight and degree of deacetylation and exposure time. Advan. Chitin Sci 4:259-265 (2000).
18. S. Walsh, A. Hopkins, J. Chen, S. Narumiya, C. Parkos, and A. Nusrat. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarised intestinal epithelia. Gastroentology 121:566-579 (2001).
19. J. Turner, E. Black, V. Guerriero, and K. Healewyn. Regulated expression of the myosin light chain kinase catalytic domain increases paracellular permeability and alters tight junction structure. Gastroentology 118 (suppl):2366 (2000).
20. P. Artursson, T. Lindmark, S. Davis, and L. Illum. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1358-1361 (1994).
21. J. Ye, T. Tsukamoto, A. Sun, and S. Nigam. A role for intracellular calcium in tight junction reassembly after ATP depletion-repletion. Am. J. Physiol. 277:F524-F553 (1999).
22. M. Lekka, P. Laidler, J. Ignacak, M. Labedz, J. Lekki, H. Struszczyk, Z. Stachura, and A. Hrynkiewitz. The effect of chitosan on stiffness and glycolytic activity of human bladder cells. Biochim. Biophys. Acta 1540:127-136 (2001).